Business

July 9, 2014

Salix shares fall 3% after merger announcement

Shares of Salix Pharmaceuticals fell 3 percent Wednesday as investors gave a muted response to the Raleigh company’s plan to merge with an Italian drug company and reincorporate in Ireland in order to lower its tax rate.

Related content

Comments

Editor's Choice Videos